Food News and Research

RSS

InfraReDx launches enhanced version of LipiScan IVUS Coronary Imaging System

InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced the launch of its TVC Imaging System, an enhanced version of the LipiScan IVUS Coronary Imaging System.

7 Nov 2011

Researchers discover key mechanism responsible for degrading ubiquitinated protein aggregates

Researchers at the RIKEN Brain Science Institute (BSI) have discovered a key mechanism responsible for selectively degrading aggregates of ubiquitinated proteins from the cell.

7 Nov 2011

Study evaluates JIA disease activity after treatment with etanercept

Among patients with juvenile idiopathic arthritis (JIA) who initiated treatment with the drug etanercept, one-third achieved an excellent response, and this response was associated with low measures of disability at study entry, younger age at the onset of JIA, and fewer disease-modifying antirheumatic drugs used before initiating etanercept, according to a study appearing in JAMA.

7 Nov 2011

IntraPace receives CE Mark for new gastric stimulation/food sensing lead

IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.

7 Nov 2011

Experts share latest buzz on allergies to alcohol and tobacco

While the health benefits of drinking wine in moderation continue to make news, for some with allergies even a glass a day may be difficult to swallow. At the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Nov. 3-8, allergists share the latest buzz on allergies to alcohol and tobacco.

7 Nov 2011

Cystic fibrosis drug shows promise in trial

The latest clinical trial in its later advanced stags found that oral drug ivacaftor (VX-77) provides major, sustained improvement in lung function, growth and other signs and symptoms for a subset of cystic fibrosis patients.

6 Nov 2011

More than half of all Americans will have diabetes by 2020

Half of all American adults are destined to develop diabetes or pre-diabetes by 2020 if they don't make dramatic lifestyle changes, according to a dire new prediction from the Centers for Disease Control and Prevention.

5 Nov 2011

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.

5 Nov 2011

Single-parent status, household income linked to increased rate of hospital readmissions of asthmatic children

Financial strain and competing priorities at home may contribute to the greater number of hospital readmissions of children with asthma from single-parent homes compared to dual-parent households, according to a new study presented at the American College of Allergy, Asthma and Immunology Annual Meeting in Boston, Nov. 3-8.

5 Nov 2011

Tackling global hunger through the empowerment of small-scale farmers

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Rick Leach, president and CEO of World Food Program USA, examines the empowerment of small-scale farmers to become active participants in the global economy as a strategy to tackle world hunger.

5 Nov 2011

Sunovion reports positive results from ciclesonide nasal aerosol Phase III study for perennial allergic rhinitis

Sunovion Pharmaceuticals Inc. today announced results from a large Phase III clinical study of ciclesonide nasal aerosol, a corticosteroid formulated with a hydrofluoroalkane (HFA) propellant, intended for the treatment of allergic rhinitis.

5 Nov 2011

State roundup: Puerto Rico settles disability battle with Feds

Puerto Rico has reached an agreement with the U.S. government ending a 12-year legal battle to improve the island's health system for the mentally disabled, local justice officials said Thursday. Federal officials had accused the U.S. territory of abusing and neglecting hundreds of mentally disabled people by not providing food, medication, adequate housing, therapy or mental health care.

5 Nov 2011

Dark, cold weather derails physical activity routines of older people with arthritis: Study

As cold winter weather sets in and daylight hours dwindle, many older Chicagoans with arthritis tend to sit idle, missing out on the daily dose of physical activity they need to improve their health, according to a Northwestern Medicine study.

5 Nov 2011

Phase III study of BG-12 in relapsing-remitting multiple sclerosis sparks excitement

Citeline, an Informa business unit, and the world's leading research authority on pharmaceutical clinical trials recently reviewed results presented at the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, a major multiple sclerosis conference which was held October 19-22, 2011 in Amsterdam.

5 Nov 2011

Results of Phase 2 program to develop NSAIDs to be reported at ACR annual meeting

The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.

5 Nov 2011

States lack policies to curb classroom burden of asthma and severe allergies

For over 7 million children with asthma, and 13 million with food allergy or other severe allergies, going to school is a daily risk affecting how well they can – or can't – manage their diseases. Now for the fourth year, the Asthma and Allergy Foundation of America has released its annual report assessing all 50 states and the District of Columbia on their leadership and progress on school-based policies that address student asthma and allergy health in more than 100,000 elementary, middle and high schools across the U.S.

5 Nov 2011

AAPM announces new plans for Safe Opioid Prescribing program

On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.

5 Nov 2011

Food News and Research

InfraReDx launches enhanced version of LipiScan IVUS Coronary Imaging System

Researchers discover key mechanism responsible for degrading ubiquitinated protein aggregates

Study evaluates JIA disease activity after treatment with etanercept

IntraPace receives CE Mark for new gastric stimulation/food sensing lead

Experts share latest buzz on allergies to alcohol and tobacco

Cystic fibrosis drug shows promise in trial

More than half of all Americans will have diabetes by 2020

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Single-parent status, household income linked to increased rate of hospital readmissions of asthmatic children

Tackling global hunger through the empowerment of small-scale farmers

Sunovion reports positive results from ciclesonide nasal aerosol Phase III study for perennial allergic rhinitis

State roundup: Puerto Rico settles disability battle with Feds

Dark, cold weather derails physical activity routines of older people with arthritis: Study

Phase III study of BG-12 in relapsing-remitting multiple sclerosis sparks excitement

Results of Phase 2 program to develop NSAIDs to be reported at ACR annual meeting

States lack policies to curb classroom burden of asthma and severe allergies

AAPM announces new plans for Safe Opioid Prescribing program

Global food prices drop but still high; market remains volatile, food indexes show

Scrip Intelligence names PPD as best contract research organization

Octapharma receives FDA approval for octagam to treat disorders of immune system

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News